We are live on ! Find out more
MD icon

Pediatrix Medical

264 hedge funds and large institutions have $1.16B invested in Pediatrix Medical in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 88 increasing their positions, 90 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 27

10% more funds holding

Funds holding: 241264 (+23)

0.46% more ownership

Funds ownership: 93.41%93.88% (+0.46%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $1.16B → $1.16B (-$4.09M)

2% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 90

Holders
264
Holders Change
+23
Holders Change %
+9.54%
% of All Funds
3.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
88
Reduced
90
Closed
27
Calls
$1.2M
Puts
Net Calls
+$1.2M
Net Calls Change
-$1.36M
Name Holding Trade Value Shares
Change
Change in
Stake
RC
76
RBF Capital
California
$1.87M
Susquehanna International Group
77
Susquehanna International Group
Pennsylvania
$1.8M -$101K -7,347 -6%
GAM
78
Gotham Asset Management
New York
$1.66M +$560K +40,822 +55%
SIM
79
SummerHaven Investment Management
Connecticut
$1.63M +$15.8K +1,153 +1%
HSBC Holdings
80
HSBC Holdings
United Kingdom
$1.59M +$1.07M +77,704 +227%
JCIA
81
Jackson Creek Investment Advisors
Colorado
$1.58M +$1.51M +110,172 New
Balyasny Asset Management
82
Balyasny Asset Management
Illinois
$1.53M +$1.24M +90,619 +568%
Federated Hermes
83
Federated Hermes
Pennsylvania
$1.47M -$837K -61,051 -37%
Lazard Asset Management
84
Lazard Asset Management
New York
$1.28M +$1.22M +89,212 New
LPL Financial
85
LPL Financial
California
$1.27M -$767K -55,919 -39%
IIM
86
INTECH Investment Management
Florida
$1.26M +$169K +12,322 +16%
T. Rowe Price Associates
87
T. Rowe Price Associates
Maryland
$1.23M +$68.5K +4,992 +6%
BHCM
88
Brevan Howard Capital Management
Jersey
$1.22M +$1.17M +85,296 New
Citigroup
89
Citigroup
New York
$1.18M -$652K -47,513 -37%
Squarepoint
90
Squarepoint
New York
$1.16M +$780K +56,889 +235%
California State Teachers Retirement System (CalSTRS)
91
California State Teachers Retirement System (CalSTRS)
California
$1.14M -$13.6K -993 -1%
WG
92
Winton Group
United Kingdom
$1.12M -$92.7K -6,760 -8%
IQI
93
Integrated Quantitative Investments
Washington
$1.06M
Canada Life
94
Canada Life
Manitoba, Canada
$1.04M +$51.7K +3,767 +5%
VRS
95
Virginia Retirement Systems
Virginia
$1.03M +$793K +57,800 +407%
GCP
96
GSA Capital Partners
United Kingdom
$1M +$960K +69,980 New
SCM
97
Sandler Capital Management
New York
$1M -$753K -54,927 -44%
WAM
98
Wakefield Asset Management
Colorado
$1M +$957K +69,791 New
Wells Fargo
99
Wells Fargo
California
$991K +$34.3K +2,498 +4%
Franklin Resources
100
Franklin Resources
California
$925K +$69.3K +5,050 +8%

MD Hedge Fund Activity: Q2 2025 in Review

264 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2025, worth a combined $1.16B — down 0.35% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new MD positions and 27 closed out — a net gain of 24 holders — while 88 added to existing stakes and 90 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $42.4M. The largest seller was AllianceBernstein, cutting an estimated $68.8M.

  • 264 institutional investors held Pediatrix Medical (MD) as of Q2 2025, up from 241 in Q1 2025.
  • Funds reported $1.16B of Pediatrix Medical stock for Q2 2025, down 0.35% quarter-over-quarter.
  • 51 funds opened new Pediatrix Medical positions in Q2 2025 and 27 closed out, a net change of +24 holders.
  • The largest Pediatrix Medical buyer in Q2 2025 was Victory Capital Management, an estimated $42.4M added.
  • The largest Pediatrix Medical seller in Q2 2025 was AllianceBernstein, an estimated $68.8M sold.

Based on aggregated 13F filings for Q2 2025.